Cerity Partners LLC Pro Phase Labs, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 94,113 shares of PRPH stock, worth $29,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,113Holding current value
$29,175% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.42MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA408KShares$126,5620.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny286KShares$88,8100.0% of portfolio
-
Citizens Financial Group Inc270KShares$83,8240.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$71,1300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA228KShares$70,5850.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.97M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...